Replimune Group, Inc (REPL) insider trading
Every open-market stock purchase and sale by Replimune Group, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $895K over the last 12 months (12 sales). No open-market buys.
- Last insider buy: Jason P Rhodes (Director), $15M, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $895K (12 sales). Last close $8.97 on Jun 7, 2026.
Recent REPL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 1, 2026 | Christopher Sarchi (C-suite exec) | Sold | $111K |
| May 18, 2026 | Sushil Patel (CEO) | Sold | $190K |
| May 18, 2026 | Philip Astley-Sparke (Director) | Sold | $89.7K |
| May 18, 2026 | Konstantinos Xynos (C-suite exec) | Sold | $71.2K |
| May 18, 2026 | Christopher Sarchi (C-suite exec) | Sold | $43.8K |
| May 18, 2026 | Andrew Schwendenman (C-suite exec) | Sold | $40.1K |
| May 18, 2026 | Emily Luisa Hill (CFO) | Sold | $39.7K |
| Apr 2, 2026 | Christopher Sarchi (C-suite exec) | Sold | $52.1K |
| Apr 1, 2026 | Philip Astley-Sparke (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Philip Astley-Sparke (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| Apr 1, 2026 | Madhavan Balachandran (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Kapil Dhingra (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Veleka Peeples-Dyer (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Sushil Patel (CEO) | Bought (not open market) | — |
| Apr 1, 2026 | Sushil Patel (CEO) | Bought (not open market) | — |
| Apr 1, 2026 | Christy J. Oliger (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Emily Luisa Hill (CFO) | Bought (not open market) | — |
| Apr 1, 2026 | Emily Luisa Hill (CFO) | Bought (not open market) | — |
| Apr 1, 2026 | Paolo Pucci (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Christopher Sarchi (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Joseph P Slattery (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Christopher Sarchi (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Konstantinos Xynos (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Konstantinos Xynos (C-suite exec) | Bought (not open market) | — |
Who's trading REPL
- Christopher Sarchi, C-suite exec: sold $254K (4 sales), last Jun 1, 2026
- Philip Astley-Sparke, Director: sold $89.7K (1 sale), last May 18, 2026
- Emily Luisa Hill, CFO: sold $39.7K (1 sale), last May 18, 2026
- Sushil Patel, CEO: sold $301K (2 sales), last May 18, 2026
- Andrew Schwendenman, C-suite exec: sold $40.1K (1 sale), last May 18, 2026
- Konstantinos Xynos, C-suite exec: sold $137K (2 sales), last May 18, 2026
- Baker Bros. Advisors LP, Insider: other filings, last Apr 1, 2026
- Joseph P Slattery, Director: other filings, last Apr 1, 2026
- Madhavan Balachandran, Director: other filings, last Apr 1, 2026
- Kapil Dhingra, Director: sold $33K (1 sale), last Apr 1, 2026
- Christy J. Oliger, Director: other filings, last Apr 1, 2026
- Dieter Weinand, Director: other filings, last Apr 1, 2026
- Veleka Peeples-Dyer, Director: other filings, last Apr 1, 2026
- Paolo Pucci, Director: other filings, last Apr 1, 2026
Get free alerts when an insider at Replimune Group, Inc files a new trade →